MedPath

Ganciclovir

Generic Name
Ganciclovir
Brand Names
Cytovene, Zirgan
Drug Type
Small Molecule
Chemical Formula
C9H13N5O4
CAS Number
82410-32-0
Unique Ingredient Identifier
P9G3CKZ4P5

Overview

An acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.

Background

An acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.

Indication

For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients.

Associated Conditions

  • CMV colitis
  • Cytomegalovirus (CMV) Infections
  • Cytomegalovirus Retinitis
  • Cytomegalovirus gastroesophagitis
  • Varicella-zoster Progressive outer retinal necrosis
  • Acute Herpetic keratitis
  • Cytomegalovirus neurological disease
  • Varicella-zoster virus acute retinal necrosis

FDA Approved Products

Ganciclovir
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:500 mg in 10 mL
Approved: 2022/09/30
NDC:63323-315
ZIRGAN
Manufacturer:Bausch & Lomb Incorporated
Route:OPHTHALMIC
Strength:1.5 mg in 1 g
Approved: 2024/02/27
NDC:24208-535
ganciclovir
Manufacturer:Sagent Pharmaceuticals
Route:INTRAVENOUS
Strength:50 mg in 1 mL
Approved: 2020/11/30
NDC:25021-185
GANCICLOVIR
Manufacturer:Ranbaxy Pharmaceuticals Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2011/10/20
NDC:63304-636
GANCICLOVIR
Manufacturer:Ranbaxy Pharmaceuticals Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2011/10/20
NDC:63304-637

Singapore Approved Products

VIRGAN EYE GEL 1.5 mg/g
Manufacturer:FARMILA-THEA FARMACEUTICI S.P.A
Form:OINTMENT
Strength:0.15g/ 100g
Online:Yes
Approved: 2002/01/18
Approval:SIN11778P
CYMEVENE FOR INJECTION 500 mg
Manufacturer:BSP Pharmaceuticals S.P.A. (DP + Primary Packager), Valdepharm (DP + Primary Packager)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:500 mg
Online:Yes
Approved: 1990/09/06
Approval:SIN05051P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath